Monthly Archives: March 2009

$100 Million Gift for AIDS Vaccine Research

By on .

The scientific search for an AIDS vaccine will get a nice lift, in the form of a $100 million gift from Massachusetts businessman Phillip Ragon. The funds will go to a new institute that hopes to harness the combined brain power of researchers from Massachusetts General Hospital, the Massachusetts Institute of Technology, and Harvard University, […]

Rajeev Venkayya On Health Delivery Systems

By on .

What are the consequences of inadequate or broken health delivery systems in developing countries? That might seem like a difficult question to answer, at least with any specificity.   But Rajeev Venkayya, director for global health delivery at the Bill & Melinda Gates Foundation, tried his best to quantify the impact of deficient health infrastructures, […]

Budget Blues

By on .

The House and Senate are moving forward on a budget that could deal a devastating blow to global health programs. But there is still time to shape the package, especially in the Senate. Last week, the Senate Budget Committee approved a plan to allocate $49.8 billion for the International Affairs Budget, the source of funding […]

Pakistan — A TB Success Story in Jeopardy

By on .

Two countries we don’t often hear about in relation to TB, Pakistan and Afghanistan, were quite prominent in the discussions here in Rio at the Stop TB Partnership Forum. Their ministers of health were here and the minister from Afghanistan spoke at the Tuesday morning plenary (be sure to watch the video online!). He noted that […]

At FDA, Torti Out, Sharfstein In, For Now

By on .

Joshua Sharfstein, the Obama administration’s nominee for the No. 2 job at the FDA, will become acting chief of the agency on Monday, according to media reports.   Here’s a news alert from InsideHealthPolicy.com   “Joshua Sharfstein, selected by the White House for the No. 2 job at FDA, will take over Monday as acting commissioner. […]

New Guidelines on Early HIV Treatment for Patients with Opportunistic Infections

By on .

The benefits of early anti-HIV therapy for patients with an opportunistic infection outweigh the risks, according to new guidelines from the CDC.   The guidelines, developed with the NIH and the Infectious Diseases Society of America, say that for most such infections, early antiretroviral therapy will lead to better outcomes.   One exception, however, is tuberculosis. […]

A Big-Picture Look at Progress, Problems in Battling HIV/AIDS

By on .

Here’s a must­-read: “AIDS: lessons learnt and myths dispelled,” in The Lancet.   The piece is written by Peter Piot, director of the Institute for Global Health at Imperial College London; Michel Kazatchkine, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria; Mark Dybul, former U.S. Global AIDS Coordinator now at Georgetown’s […]